Four-year recurrence-free survival in metastatic uterine adenosarcoma with somatic BRCA2 mutation on olaparib therapy: A case report

• DOI: 10.1016/j.gore.2025.101724
• Publication Date: 2025-03-20T02:16:41Z
• Authors: Katie Foug; Stephanie L. Skala; Erica Stein; Kevin Reynolds; Jean Siedel; Shitanshu Uppal
• Keywords: Olaparib